Total Payments
$60,051
2024 Payments
$14,056
Companies
12
Transactions
65
Medicare Patients
691
Medicare Billing
$147,036
Payment Breakdown by Category
Consulting$47,132 (78.5%)
Travel$4,203 (7.0%)
Research$3,980 (6.6%)
Other$3,440 (5.7%)
Food & Beverage$1,284 (2.1%)
Education$11.92 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $47,132 | 20 | 78.5% |
| Travel and Lodging | $4,203 | 16 | 7.0% |
| Unspecified | $3,980 | 2 | 6.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $3,440 | 4 | 5.7% |
| Food and Beverage | $1,284 | 22 | 2.1% |
| Education | $11.92 | 1 | 0.0% |
Payments by Type
General
$56,071
63 transactions
Research
$3,980
2 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| EISAI INC. | $12,563 | 11 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $8,935 | 6 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $8,881 | 8 | $0 (2018) |
| Daiichi Sankyo Inc. | $6,711 | 8 | $0 (2022) |
| PFIZER INC. | $6,580 | 5 | $0 (2020) |
| Gilead Sciences, Inc. | $5,646 | 9 | $0 (2024) |
| AbbVie, Inc. | $4,264 | 10 | $0 (2019) |
| Genentech USA, Inc. | $2,867 | 3 | $0 (2024) |
| F. Hoffmann-La Roche AG | $2,130 | 2 | $0 (2019) |
| Seagen Inc. | $1,375 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $14,056 | 16 | Gilead Sciences, Inc. ($5,634) |
| 2023 | $53.73 | 2 | AstraZeneca Pharmaceuticals LP ($30.00) |
| 2022 | $8,895 | 5 | AstraZeneca Pharmaceuticals LP ($3,425) |
| 2021 | $2,052 | 2 | Eisai Co., Ltd. ($2,040) |
| 2020 | $10,718 | 5 | Daiichi Sankyo Inc. ($4,375) |
| 2019 | $6,675 | 17 | AbbVie, Inc. ($4,264) |
| 2018 | $12,327 | 14 | Novartis Pharmaceuticals Corporation ($6,207) |
| 2017 | $5,274 | 4 | Novartis Pharmaceuticals Corporation ($2,674) |
All Payment Transactions
65 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $2,055.00 | General |
| 12/16/2024 | Gilead Sciences, Inc. | Trodelvy (Drug) | Travel and Lodging | In-kind items and services | $45.00 | General |
| Category: ONC | ||||||
| 12/16/2024 | Gilead Sciences, Inc. | Trodelvy (Drug) | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: ONC | ||||||
| 12/11/2024 | AstraZeneca UK Limited | — | Food and Beverage | In-kind items and services | $75.54 | General |
| 12/11/2024 | Gilead Sciences, Inc. | Trodelvy (Drug) | Food and Beverage | In-kind items and services | $60.00 | General |
| Category: ONC | ||||||
| 12/10/2024 | Genentech USA, Inc. | Itovebi (Biological) | Consulting Fee | Cash or cash equivalent | $2,280.00 | General |
| Category: BioOncology | ||||||
| 12/10/2024 | Genentech USA, Inc. | Itovebi (Biological) | Travel and Lodging | Cash or cash equivalent | $358.18 | General |
| Category: BioOncology | ||||||
| 12/10/2024 | Genentech USA, Inc. | Itovebi (Biological) | Food and Beverage | In-kind items and services | $228.46 | General |
| Category: BioOncology | ||||||
| 12/09/2024 | Gilead Sciences, Inc. | Trodelvy (Drug) | Consulting Fee | Cash or cash equivalent | $4,580.00 | General |
| Category: ONC | ||||||
| 11/15/2024 | Gilead Sciences, Inc. | Trodelvy (Drug) | Food and Beverage | In-kind items and services | $60.00 | General |
| Category: ONC | ||||||
| 11/15/2024 | Gilead Sciences, Inc. | Trodelvy (Drug) | Food and Beverage | In-kind items and services | $58.00 | General |
| Category: ONC | ||||||
| 11/15/2024 | Gilead Sciences, Inc. | Trodelvy (Drug) | Food and Beverage | In-kind items and services | $57.00 | General |
| Category: ONC | ||||||
| 11/14/2024 | Gilead Sciences, Inc. | Trodelvy (Drug) | Travel and Lodging | In-kind items and services | $759.95 | General |
| Category: ONC | ||||||
| 10/17/2024 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $1,370.00 | General |
| 08/01/2024 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $685.00 | General |
| 02/05/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Consulting Fee | Cash or cash equivalent | $1,370.00 | General |
| Category: Oncology | ||||||
| 12/05/2023 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $30.00 | General |
| 11/13/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $23.73 | General |
| 12/16/2022 | Daiichi Sankyo Inc. | ENHERTU (Drug) | Consulting Fee | Cash or cash equivalent | $1,370.00 | General |
| Category: ONCOLOGY | ||||||
| 12/16/2022 | Daiichi Sankyo Inc. | ENHERTU (Drug) | Consulting Fee | Cash or cash equivalent | $685.00 | General |
| Category: ONCOLOGY | ||||||
| 08/19/2022 | Seagen Inc. | TUKYSA (Drug) | Consulting Fee | Cash or cash equivalent | $1,375.00 | General |
| Category: Oncology | ||||||
| 08/02/2022 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $3,425.00 | General |
| 07/18/2022 | EISAI INC. | Halaven (Drug) | Consulting Fee | Cash or cash equivalent | $2,040.00 | General |
| Category: Oncology | ||||||
| 10/07/2021 | Eisai Co., Ltd. | Halaven (Drug) | Consulting Fee | Cash or cash equivalent | $2,040.00 | General |
| Category: Oncology | ||||||
| 06/01/2021 | Gilead Sciences, Inc. | — | Education | In-kind items and services | $11.92 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| ENZALUTAMIDE CLINICAL PUBLICATION PROGRAM | PFIZER INC. | $3,980 | 2 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 107 | 225 | $97,206 | $22,464 |
| 2022 | 3 | 140 | 308 | $134,751 | $30,608 |
| 2021 | 4 | 183 | 495 | $202,476 | $47,274 |
| 2020 | 6 | 261 | 650 | $233,363 | $46,691 |
Total Patients
691
Total Services
1,678
Medicare Billing
$147,036
Procedure Codes
16
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 78 | 196 | $84,084 | $19,616 | 23.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 13 | 13 | $8,034 | $1,780 | 22.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 16 | 16 | $5,088 | $1,067 | 21.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 71 | 237 | $101,673 | $23,663 | 23.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 35 | 35 | $21,630 | $4,762 | 22.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 34 | 36 | $11,448 | $2,183 | 19.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 91 | 376 | $161,304 | $38,190 | 23.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 54 | 63 | $20,034 | $3,745 | 18.7% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 26 | 26 | $16,068 | $3,685 | 22.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 12 | 30 | $5,070 | $1,654 | 32.6% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 79 | 378 | $151,854 | $29,953 | 19.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 90 | 134 | $38,769 | $6,437 | 16.6% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 45 | 45 | $25,052 | $5,060 | 20.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 21 | 60 | $10,140 | $3,155 | 31.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 11 | 18 | $4,968 | $1,406 | 28.3% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 15 | 15 | $2,580 | $679.92 | 26.4% |
About Dr. Vandana Abramson, MD
Dr. Vandana Abramson, MD is a Internal Medicine healthcare provider based in Nashville, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1154359602.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Vandana Abramson, MD has received a total of $60,051 in payments from pharmaceutical and medical device companies, with $14,056 received in 2024. These payments were reported across 65 transactions from 12 companies. The most common payment nature is "Consulting Fee" ($47,132).
As a Medicare-enrolled provider, Abramson has provided services to 691 Medicare beneficiaries, totaling 1,678 services with total Medicare billing of $147,036. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Medical Oncology
- Location Nashville, TN
- Active Since 06/30/2006
- Last Updated 03/23/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1154359602
Products in Payments
- Halaven (Drug) $12,563
- XTANDI (Drug) $6,580
- KISQALI (Drug) $6,207
- Trodelvy (Drug) $5,634
- Enhertu (Drug) $4,656
- Venclexta (Drug) $4,264
- Itovebi (Biological) $2,867
- TYKERB (Drug) $2,674
- Non-Covered Product (Drug) $2,130
- ENHERTU (Drug) $2,055
- TUKYSA (Drug) $1,375
- LYNPARZA (Drug) $1,370
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Nashville
Mr. John Anderson, Md, MD
Internal Medicine — Payments: $2.1M
Internal Medicine $2.1M
Sandeep Rajan, M.d, M.D
Internal Medicine — Payments: $709,151
Internal Medicine $709,151
Dr. Christopher Ellis, M.d, M.D
Internal Medicine — Payments: $618,290
Internal Medicine $618,290
Dr. Brian Jefferson, Md, MD
Internal Medicine — Payments: $514,499
Internal Medicine $514,499
Dr. Robert Ramirez, D.o, D.O
Internal Medicine — Payments: $467,030
Internal Medicine $467,030
Dr. Michael Morse, M.d, M.D
Internal Medicine — Payments: $444,237
Internal Medicine $444,237